Erratum

With apologies from the author, in the article entitled, “Combination Therapy for Neovascular Age-related Macular Degeneration Refractory to Anti-Vascular Endothelial Growth Factor Agents” by Kevin Tozer, MD, A. Brock Roller, MD, Lawrence P. Chong, MD, et al (Ophthalmology 2013;120:2029-34), which appeared in the October 2013 issue, on page 2031, should have read (correction in boldface): By 6 months after combination treatment, 76 retreatments were administered: 69 eyes had only repeat anti-VEGF injections, 4 eyes received repeat anti-VEGF and PDT combination therapy (1 combination and 1 anti-VEGF treatment, 1 combination and 2 anti-VEGF treatments, 1 combination and 3 anti-VEGF treatments, and 1 combination treatment only, respectively), and 3 eyes did not require retreatment (Table 3, available at http://aaojournal.org).